I execute the Competitive Intelligence (CI) and Market Intelligence (MI) vision and strategy, in alignment with stakeholder priorities at senior leadership level. I work closely with disease area matrix teams (including leaders and teams in Commercial, Medical, & Market Access as well as SMO) to provide strategic support through the identification, analysis, and distribution of timely & relevant business and competitive intelligence and actionable insights that inform the near and long term franchise strategies.

Our purpose is to discover new ways to improve and extend people's lives. We contribute to society's ability to support growing healthcare needs by pioneering novel approaches to help people around the world access high-quality medicine. Our global portfolio comprises approximately 1,000 molecules, covering all major therapeutic areas, which accounted for 2019 sales of USD 9.7 billion. Our products reach more than 500 million patients.